A CDSCO operation theatre medical device license is mandatory under India's Medical Devices Rules, 2017 for any manufacturer or importer of notified OT devices. Operation theatre devices span all four CDSCO classes (A through D). Manufacturing Class A and B OT devices requires a Form MD5 license from the State Licensing Authority (government fee: Rs. 5,000 plus Rs. 500 per device). Manufacturing Class C and D OT devices requires a Form MD9 license from CDSCO — the Central Licensing Authority (fee: Rs. 50,000 plus Rs. 1,000 per device). Importing any class of OT device requires a Form MD15 import license from CDSCO. All three license types are valid indefinitely, subject to a retention fee paid every 5 years. Applications are submitted through the CDSCO SUGAM portal (cdscoonline.gov.in). ISO 13485 certification and a Device Master File are mandatory documents for all manufacturing license applications.
Operation theatres represent some of the most demanding environments in healthcare — environments where device performance, reliability, and safety are not abstract regulatory standards but direct determinants of surgical outcomes and patient lives. The CDSCO framework recognises this: under the Medical Devices Rules, 2017, operation theatre medical devices are subject to mandatory licensing requirements that apply to every manufacturer and importer of notified devices, without exception based on device size, quantity, or the scale of the business seeking to enter the market.
For manufacturers and importers of surgical tables, electrosurgical units, anaesthesia machines, multiparameter monitors, surgical lights, forceps, scalpels, or any of the wide range of devices that support surgical activity, understanding the CDSCO licensing pathway is the essential first step in a legally compliant India market entry. This guide provides that understanding — from device classification through license type selection, mandatory documents, the application process, and post-grant compliance requirements.
📑 Quick Navigation
- Operation Theatre Medical Devices — Role and Regulatory Context
- CDSCO Device Classification System
- CDSCO Classification of Operation Theatre Devices by Class
- Three CDSCO License Types for OT Devices: MD5, MD9, MD15
- License Validity and Retention Fee Requirements
- Mandatory Documents for CDSCO OT Device License Application
- 6-Step Application Process Through CDSCO SUGAM
- 5 Benefits of CDSCO Licensing for OT Device Manufacturers
- How Rego Services Supports Your CDSCO Application
- Frequently Asked Questions
Operation Theatre Medical Devices — Role and Regulatory Context
An operation theatre (OT) — also referred to as an operating room (OR) — is a tightly controlled clinical environment in which surgical procedures are performed under conditions of strict sterility, regulated airflow and temperature, and precisely calibrated lighting. The medical devices present in an operation theatre are not peripheral to the surgical act — they are integral to its execution. Surgical tables position patients for operative access. Anaesthesia machines manage sedation and airway. Multiparameter monitors track haemodynamics and oxygen saturation in real time. Electrosurgical units coagulate and dissect tissue. Surgical lighting systems illuminate the operative field. Each of these devices must function reliably, precisely, and safely — every time, without exception.
This dependency of surgical outcomes on device performance is the reason CDSCO regulation of operation theatre medical devices is mandatory and non-negotiable. Under the Medical Devices Rules, 2017, any company manufacturing or importing notified medical devices in India — including the full spectrum of OT devices from basic surgical instruments to advanced robotic surgical systems — must hold a valid CDSCO license before placing those devices on the Indian market.
CDSCO Device Classification System
The Medical Devices Rules, 2017 classify all notified medical devices into four risk-based classes. The classification system is designed to calibrate regulatory requirements to the level of patient risk associated with a device's intended use — applying more demanding licensing requirements to higher-risk devices and streamlining the pathway for lower-risk devices. Understanding this system is the mandatory first step in any CDSCO licensing strategy, because the device class determines which license applies, which authority issues it, and what the associated government fees are.
Devices that present the lowest level of risk to the patient or user. These are typically non-invasive devices or devices with limited body contact. Class A devices that are non-sterile and non-measuring are not required to obtain a manufacturing license but must still comply with applicable quality and labelling requirements. Class A devices that are sterile or measuring require an MD5 license.
Devices presenting a low to moderate risk level, typically with short-term body contact or indirect patient interaction. Class B devices require an MD5 manufacturing license from the State Licensing Authority. The classification covers a wide range of surgical instruments and OT support equipment that interact with the patient in a limited or non-critical manner.
Devices presenting a moderate to high risk — typically those that interact directly with critical physiological systems, are surgically invasive, or whose malfunction could cause serious harm. Class C devices require an MD9 manufacturing license from the Central Licensing Authority (CDSCO). Most active OT devices — electrosurgical units, anaesthesia machines, multiparameter monitors — fall in this class.
The highest-risk device category — devices that interact with critical organs or life-sustaining systems, or whose failure has a high probability of causing permanent injury or death. Class D devices carry the most demanding regulatory requirements, including more extensive clinical evidence requirements and the most rigorous CDSCO review. Class D manufacturing licenses (MD9) require a Device Master File accepted by CDSCO's central authority.
CDSCO Classification of Operation Theatre Devices by Class
The following provides a class-by-class breakdown of operation theatre medical devices under the CDSCO classification system. This is not an exhaustive list — the full classification schedule under MDR 2017 contains hundreds of device categories. These examples are provided to illustrate the classification logic and to assist manufacturers and importers in identifying the likely class of their specific OT device before engaging with the formal classification confirmation process.
- Distractor / Retractors
- Suction system — portable, electrical / pneumatic
- Suction system operated by vacuum
- Manually-operated general-purpose operation table
- General-purpose diagnosis / treatment table
- Surgical light system
- Motorised diagnostic imaging view box
- Haemostatic clip applier
- Haemostatic knife
- Scalpel and scalpel blade
- Surgical forceps
- Surgical punch / file / probe
- Blood vessel surgical stripper
- Powered general-purpose operation table
- Staple remover
- General-purpose electrosurgical unit
- Multiparameter monitor with critical parameters
- Surgical robot unit
- Warming high-flow infusion pump
- High-flow blood transfusion pump
- Long-term use enterostomy feeding tube
- Gastrostomy tube for long-term use
- Anaesthesia machines with ventilator integration
- Cardiopulmonary bypass equipment
- Implantable devices used intraoperatively
- High-risk electrosurgical systems for critical procedures
- Devices in direct contact with central circulatory / CNS systems
Three CDSCO License Types for OT Devices: MD5, MD9, MD15
The CDSCO licensing framework for operation theatre medical devices provides three distinct license types, determined by whether the company is manufacturing or importing, and — for manufacturers — the risk class of the device. Understanding which license applies to your specific situation is essential before beginning the application process, as each license type has distinct document requirements, government fees, and reviewing authorities.
CDSCO Medical Device Test License (MD13 / MD17) India 2026 — Complete Guide
If you are a first-time manufacturer of operation theatre medical devices and need to produce initial production batches to generate the Certificate of Analysis required for your MD5 or MD9 application, a CDSCO test license (MD13) is the legally required first step. This guide covers everything you need to know about test licenses, including the 5-step application process and mandatory documents.
License Validity and Retention Fee Requirements
One of the important features of the CDSCO operation theatre medical device license — whether MD5, MD9, or MD15 — is that it is issued with indefinite validity. Unlike many regulatory authorisations in other jurisdictions that require periodic renewal, CDSCO licenses under MDR 2017 do not expire on a fixed date. However, this indefinite validity is conditional: the license retention fee must be paid every five years to keep the license in active status.
| Parameter | MD5 (Mfg Class A/B) | MD9 (Mfg Class C/D) | MD15 (Import) |
|---|---|---|---|
| Validity period | Indefinite | Indefinite | Indefinite |
| Retention fee cycle | Every 5 years | Every 5 years | Every 5 years |
| Consequence of non-payment | License may lapse; fresh application may be required | License may lapse; fresh application may be required | License may lapse; fresh application may be required |
| Issuing authority | State Licensing Authority | CDSCO (Central) | CDSCO (Central) |
| Initial license fee | Rs. 5,000 + Rs. 500/device | Rs. 50,000 + Rs. 1,000/device | Class-dependent |
Mandatory Documents for CDSCO OT Device License Application
The document requirements for CDSCO operation theatre medical device license applications are defined under the Medical Devices Rules, 2017 and associated CDSCO guidance documents. While the precise document set varies by license type and device class, the following represents the core mandatory documentation required across MD5, MD9, and MD15 applications. Quality and completeness of the document set is the single largest determinant of application review time — thorough preparation before submission consistently produces faster outcomes than managing queries after submission.
- Sale Deed or Rent Agreement for the manufacturing or registered premises — Valid documentary evidence of the applicant's right to occupy the declared premises. For manufacturing license applications, this covers the manufacturing facility. For import license applications, this covers the registered office or warehouse from which imported devices will be distributed.
- Organisation identity proof — Certificate of Incorporation, Memorandum and Articles of Association, GST registration certificate, and other applicable entity identity documents establishing the legal status and identity of the applicant company.
- Building layout with dimensions — An accurate, dimensioned floor plan of the manufacturing facility, prepared in accordance with CDSCO requirements, showing production areas, quality control laboratory, storage areas, and personnel facilities. For Class C and D devices, the layout must demonstrate GMP-compliant facility design.
- Qualified and experienced personnel documentation — Curriculum vitae, educational qualifications, and appointment letters for the technical team responsible for manufacture, quality control, and quality assurance. CDSCO specifies minimum qualification levels for key personnel — the documentation must demonstrate that these requirements are met.
- Device Master File (DMF) — A comprehensive technical dossier covering the device's design, intended use, manufacturing process, risk management, testing and performance data, biocompatibility information (where applicable), labelling and Instructions for Use, and post-market surveillance plan. The Device Master File is one of the most complex and time-consuming documents to prepare — and its quality is one of the most significant determinants of whether the application progresses smoothly or generates extensive reviewer queries.
- Plant Master File (PMF) — A comprehensive document describing the manufacturing facility — its location, physical layout, manufacturing process flows, equipment list, calibration and maintenance programme, cleaning and sanitation procedures, environmental monitoring systems, and quality management infrastructure. For Class C and D manufacturing, the PMF must demonstrate GMP compliance consistent with ISO 13485 requirements.
- Certificate of Analysis for three consecutive production batches — This is the document that proves the applicant's manufacturing process is capable of consistently producing devices that meet the declared specifications. For first-time manufacturers, these batches must be produced under a valid CDSCO test license (MD13) before the permanent manufacturing license application can be submitted.
- ISO 13485 Certificate — A current, in-scope ISO 13485 certificate from an IAF-accredited certification body. The certificate must cover the manufacturing activities relevant to the operation theatre device. This is a mandatory hard requirement for all manufacturing license applications — without it, the application cannot proceed.
- Test License (if applicable) — Where the three consecutive batch certificates were produced under an MD13 test license, a copy of that license must be included as a supporting document to contextualise the batch data.
- Environmental regulation compliance documents — Where the manufacturing process generates regulated waste streams, applicable environmental compliance documentation (pollution control board clearances, waste disposal agreements) must be included.
Of all the mandatory documents, the Device Master File and the Plant Master File require the most preparation time and generate the most reviewer queries when incomplete. Both should be begun as early as possible in the licensing timeline — ideally during or immediately after ISO 13485 certification, since much of the underlying content (process descriptions, risk management files, quality control procedures) is developed as part of the QMS implementation process. Treating the DMF and PMF as parallel workstreams to ISO 13485 certification, rather than sequential tasks begun after certification is complete, can compress the overall time to license grant by several months.
6-Step Application Process Through CDSCO SUGAM
All CDSCO operation theatre medical device license applications — MD5, MD9, and MD15 — are submitted, tracked, and managed through the CDSCO SUGAM online portal at cdscoonline.gov.in. The portal handles document upload, fee payment, query correspondence, inspection scheduling, and license issuance. The application process follows six structured steps.
Before any application activity begins, confirm the CDSCO class of your operation theatre device under the Medical Devices Rules, 2017 schedule. The class determines the license type (MD5, MD9, or MD15), the reviewing authority (State or Central), and the applicable fee structure. A misclassified application wastes fees and document preparation effort and must be restarted. Rego Services confirms classification as the first step in all licensing engagements.
Compile all required documents — ISO 13485 certificate, Device Master File, Plant Master File, Certificate of Analysis for three consecutive batches, premises documents, qualified personnel documents, and all other supporting materials specific to your device class and license type. For manufacturing licenses, the Device Master File and Plant Master File are the most technically demanding documents and typically require the most preparation time. Applications should not be submitted until the document set is complete and internally reviewed for consistency.
Create a company account at cdscoonline.gov.in or log in to an existing account. Ensure portal registration details — legal entity name, address, GST number — exactly match the identity documents being submitted. Select the applicable license application form: the form for MD5, MD9, or MD15 as determined by the device classification. Upload all mandatory documents in the required file formats and sizes specified by the portal.
Pay the applicable government fee through the SUGAM portal's integrated payment system. The fee is determined by the license type and the number of devices being covered. For MD5 applications: Rs. 5,000 plus Rs. 500 per distinct device. For MD9 applications: Rs. 50,000 plus Rs. 1,000 per distinct device. Retain the digital payment receipt and application reference number. The application is formally submitted on payment completion — prior to payment, it remains in draft status and has not been received by the reviewing authority.
The licensing authority reviews the submitted application and documents. Written queries may be raised through the portal — these must be addressed accurately and within the specified timeframe. For manufacturing licenses (MD5 and MD9), a physical facility inspection by regulatory officials is typically conducted before the license is granted. During the inspection, officials will assess whether the manufacturing infrastructure, quality management systems, personnel qualifications, and production processes match what is declared in the Plant Master File and Device Master File.
Once all criteria are satisfied, inspection findings are cleared, and any outstanding queries resolved, the CDSCO license is issued through the SUGAM portal. Post-grant, the license holder must maintain ongoing compliance with the Medical Devices Rules, 2017 — including maintaining ISO 13485 certification, adhering to adverse event reporting requirements, maintaining post-market surveillance, and paying the license retention fee every five years. CDSCO may conduct post-market surveillance inspections at any point during the license period.
ISO 13485 Certification in India 2026 — Complete Guide
ISO 13485 certification is a mandatory document for all CDSCO manufacturing license applications, including for operation theatre medical devices. If ISO 13485 is not yet in place, it must be obtained before the MD5 or MD9 application can be submitted. This guide covers all 8 ISO 13485 clauses, the 10-step certification process, and how Rego Services supports manufacturers through gap analysis, QMS documentation, and certification body audit preparation.
5 Benefits of CDSCO Licensing for OT Device Manufacturers
A valid CDSCO license is the essential legal prerequisite for placing operation theatre medical devices on the Indian market. Without it, manufacture or import for commercial sale is prohibited under the Medical Devices Rules, 2017. Obtaining the license converts market entry from a regulatory risk to a structured, defensible commercial launch. India's healthcare infrastructure is expanding significantly — new hospital construction, surgical volume growth, and government health scheme programmes all create sustained demand for quality OT devices from licensed manufacturers and importers.
CDSCO licensing demonstrates to hospital procurement teams, surgeons, and health system administrators that the devices they are procuring have been evaluated against mandatory Indian regulatory standards and that the manufacturer or importer operates a quality management system audited to ISO 13485. In a segment as safety-critical as operation theatre equipment, CDSCO licensing is not merely a regulatory box-tick — it is a credibility signal that influences procurement decisions and supports long-term commercial relationships with major Indian hospital groups.
Operation theatre medical devices imported into India without a valid CDSCO MD15 import license face customs detention, potential seizure, and significant costs associated with re-export or destruction of goods. A valid MD15 license provides the customs authorities with the documentary authorisation they require to clear OT device shipments — preventing disruptions to supply chains, hospital delivery timelines, and the commercial relationships that depend on reliable device availability. In a hospital environment where OT schedules are tightly managed, supply chain reliability is a competitive differentiator.
A significant and growing share of operation theatre equipment procurement in India flows through government channels — central and state government hospital tender processes, AYUSHMAN BHARAT empanelled hospital procurement, and central health ministry equipment upgrade programmes. Participation in these tender processes as a supplier of OT devices requires CDSCO licensing. Companies without a valid license are ineligible to tender, regardless of the quality of their devices. The CDSCO license is therefore not only a regulatory requirement but a commercial prerequisite for accessing government healthcare procurement.
Once in place, a CDSCO license with indefinite validity (subject to retention fee) provides a stable regulatory foundation on which to build and grow an India business over time — adding new device models, expanding distribution, engaging with new hospital customers, and responding to tenders — without the uncertainty of periodic license renewal. Manufacturers and importers who invest in obtaining and maintaining their CDSCO license early build a regulatory position that becomes a durable competitive advantage as the Indian healthcare market continues to expand.
How Rego Services Supports Your CDSCO OT Device License Application
Rego Services Private Limited provides end-to-end support for CDSCO operation theatre medical device license applications — covering MD5 (Class A and B manufacturing), MD9 (Class C and D manufacturing), and MD15 (import) across all OT device categories. Our regulatory team brings deep experience in CDSCO document preparation, State and Central Licensing Authority processes, and the specific technical requirements for operation theatre device applications at every risk class.
- Device classification confirmation and licensing strategy — We confirm the CDSCO class of your operation theatre device, identify the applicable license type, and develop a complete regulatory strategy — including whether a test license (MD13) is required before the permanent manufacturing license application, and how ISO 13485 certification fits into the overall timeline.
- ISO 13485 certification support — If ISO 13485 certification is not yet in place, we support the full certification process — quality management system gap analysis, documentation development, implementation support, internal audit preparation, and certification body liaison — on a timeline coordinated with the CDSCO license application to avoid gaps or delays.
- Device Master File preparation — We prepare comprehensive, CDSCO-compliant Device Master Files for operation theatre devices across all classes — incorporating device description, design documentation, risk management files, testing and performance data, biocompatibility summaries, labelling, Instructions for Use, and post-market surveillance plans.
- Plant Master File preparation — We prepare Plant Master Files that accurately and completely describe the manufacturing facility in the format and level of detail that CDSCO reviewing authorities expect — covering facility layout, manufacturing process flows, equipment lists, cleaning and sanitation, environmental monitoring, and quality management infrastructure.
- Certificate of Analysis and batch record support — We support the planning and documentation of the three consecutive batch production runs required for MD5 and MD9 applications, ensuring batch records are prepared to the standard required by CDSCO reviewers and auditors.
- SUGAM portal submission management — We manage the complete online submission process — portal registration, form selection, document upload, fee payment, and formal application submission — eliminating procedural errors that delay the start of the review clock.
- Query response and inspection preparation — We draft and coordinate responses to CDSCO reviewer queries, drawing on our experience of common query patterns for OT device applications to provide targeted, evidence-based responses. For manufacturing license applications, we prepare the facility and personnel for CDSCO inspection, including mock inspection exercises and corrective action planning.
- Post-grant compliance monitoring — We support ongoing compliance with license conditions, maintain retention fee due date calendars, support adverse event reporting, and assist with the addition of new device models to existing licenses as the business grows.
Frequently Asked Questions
Can one CDSCO license cover multiple operation theatre devices?
Yes. An MD5, MD9, or MD15 license can cover multiple distinct operation theatre medical devices within the same risk class, provided each device is individually declared in the application with its own device description, classification confirmation, and associated technical documentation. The per-device fee applies for each distinct device covered. Where an applicant manufactures or imports both Class A/B and Class C/D devices, separate MD5 and MD9 licenses are required. Rego Services advises on the most efficient approach to multi-device license applications, including the sequencing of applications to optimise total licensing cost and timeline.
Do imported operation theatre devices require a Free Sale Certificate from the country of origin?
Yes. For MD15 import license applications, a Free Sale Certificate (or equivalent marketing authorisation document) from the regulatory authority in the country of origin of the device is typically required as part of the supporting documentation. The specific document requirements for import license applications vary depending on the device class and whether the foreign manufacturer has an existing regulatory authorisation in a recognised reference market. Rego Services advises on country-of-origin documentation requirements as part of MD15 application preparation.
What qualifications must the technical head at an OT device manufacturing facility have under MDR 2017?
The Medical Devices Rules, 2017 specify minimum qualification requirements for the qualified technical person responsible for manufacturing operations at a licensed facility. For most operation theatre medical device categories, the qualified person must hold a degree in an appropriate science, engineering, or medical discipline and have relevant practical experience in medical device manufacture or quality systems. The specific qualification requirements are device-category and class-dependent. Rego Services reviews the qualifications of the proposed technical team as part of MD5 and MD9 application preparation and advises on any gaps that need to be addressed before the license application is submitted.
Is a separate license required for each manufacturing facility location?
Yes. Each distinct manufacturing facility requires its own separate CDSCO manufacturing license. A license issued for a facility at one address does not authorise manufacture at a different address — even if both facilities belong to the same company. If a manufacturer operates multiple sites, each site must have its own valid MD5 or MD9 license. The document requirements — including Plant Master File and facility inspection — apply separately to each site. Import licenses (MD15) are linked to the importer's registered entity rather than a specific facility address, subject to the declared storage and distribution infrastructure.
How long does it typically take to obtain a CDSCO manufacturing license for an operation theatre medical device?
The timeline depends on the device class, the completeness of the initial application, and the workload of the reviewing authority at the time of submission. As a general planning reference: MD5 applications for Class A and B devices at the State Licensing Authority level typically take 3 to 6 months from submission to license grant when the application is complete and no major queries arise. MD9 applications for Class C and D devices at CDSCO central level typically take 6 to 12 months or more, given the more complex document requirements and the central review process. Applications with incomplete documents, significant queries, or inspection observations that require remediation will take longer. Rego Services works to maximise the completeness of initial submissions to minimise query cycles and compress overall timelines.
✓ Key Takeaways
- A CDSCO license is mandatory under MDR 2017 for all manufacturers and importers of notified operation theatre medical devices in India — there are no exemptions based on device size, quantity, or business scale
- OT devices are classified across all four CDSCO risk classes (A through D) based on intended use, mechanism of action, and patient contact characteristics — confirming the correct class before beginning the license application is essential
- Three license types apply: MD5 (manufacture Class A/B — State Licensing Authority, Rs. 5,000 + Rs. 500/device), MD9 (manufacture Class C/D — CDSCO Central, Rs. 50,000 + Rs. 1,000/device), and MD15 (import all classes — CDSCO Central)
- All three license types have indefinite validity — but a retention fee must be paid every 5 years to maintain the license in active status; non-payment may require a fresh application
- ISO 13485 certification is a mandatory document for all manufacturing license applications (MD5 and MD9) — it must be in place before the license application can be submitted
- The Device Master File and Plant Master File are the most technically complex mandatory documents — their quality and completeness is the primary determinant of application review speed and outcome
- First-time manufacturers who do not yet have production batch data will likely need a CDSCO test license (MD13) before applying for the permanent manufacturing license, to lawfully produce the three consecutive batch Certificate of Analysis reports required as mandatory documents
- Applications are submitted entirely through the CDSCO SUGAM portal — manufacturing license applications include a physical facility inspection before the license is granted
Your Next Step
Operation theatre medical devices sit at the intersection of precision engineering and patient safety — and CDSCO's licensing framework reflects that reality. For manufacturers of surgical tables, electrosurgical units, anaesthesia machines, monitoring systems, and surgical instruments, and for importers bringing international OT technology into the Indian market, the CDSCO license is not simply a regulatory formality. It is the documented proof that your devices and your manufacturing or distribution systems meet the standards that Indian hospitals and patients have a right to expect.
The path to that license — from confirming device classification through ISO 13485 certification, Device Master File preparation, Plant Master File development, batch production data, SUGAM portal submission, query management, and facility inspection — is a structured process that rewards careful planning and expert preparation. Companies that invest in getting the fundamentals right at each stage consistently achieve faster license grant timelines and build stronger foundations for post-grant compliance than those who treat the application as an administrative process to be completed as quickly as possible.
Rego Services' regulatory team has supported manufacturers and importers of operation theatre medical devices across all CDSCO device classes through the licensing process. Our approach combines technical rigour in document preparation with practical knowledge of what State Licensing Authority and CDSCO central reviewers examine most closely in OT device applications — enabling us to prepare submissions that are complete, accurate, and structured to move through the review process efficiently.
Contact Rego Services today to discuss your CDSCO operation theatre medical device license requirements and receive a clear, timeline-specific regulatory plan tailored to your device and your India market entry goals.